Bifidobacteriaceae Family Diversity in Gut Microbiota of Patients with Renal Failure

سال انتشار: 1400
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 47

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_ARCHRAZI-76-3_012

تاریخ نمایه سازی: 6 دی 1402

چکیده مقاله:

Bifidobacteriaceae family are gut microbiota that exhibit probiotic or health promoting effects on the host. Several studies have suggested that gut microbiota are quantitatively and qualitatively altered in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). The present study aimed to assess the members of Bifidobacteriaceae family in fecal samples of patients with CKD and ESRD and compare them with non-CKD/ESRD patients to find any changes in their counts and diversions in these patients. Twenty fresh fecal samples from patients with CKD/ESRD and twenty from non-CKD/ESRD patients were examined. Whole DNA was extracted from fecal samples and the gut microbiota composition was analyzed by next generation sequencing (NGS). A total of ۶۵۱ strains were identified from ۴۰ fecal samples, ۸ (۱.۲۳%) strains of which were identified as family Bifidobacteriaceae. The most abundant species in both control and disease groups were Bifidobacterium adolescentis and Bifidobacterium longum subsp. longum, and the least abundant species in the disease group was Bifidobacterium animalis subsp. lactis. There was no significant difference in the abundance of various species between the disease and control groups (p < ۰.۰۵). This study confirms that the members of the Bifidobacteriaceae family are not altered in patients with CKD/ESRD.

کلیدواژه ها:

Bifidobacteriaceae ، Chronic Kidney Disease (CKD) ، End-Stage Renal Disease (ESRD) ، Next Generation Sequencing (NGS)

نویسندگان

Gh. R Hanifi

Department of Microbiology, Zanjan Branch, Islamic Azad University, Zanjan, Iran

H Samadi Kafil

Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

H Tayebi Khosroshahi

Kidney Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

R. Shapouri

Department of Microbiology, Zanjan Branch, Islamic Azad University, Zanjan, Iran

M Asgharzadeh

Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • Hooper LV, Midtvedt T, Gordon JI. How host-microbial interactions shape ...
  • Leahy SC, Higgins DG, Fitzgerald GF, van Sinderen D. Getting ...
  • O'Hara AM, Shanahan F. Mechanisms of action of probiotics in ...
  • Reinhardt C, Reigstad CS, Backhed F. Intestinal microbiota during infancy ...
  • Azcarate-Peril MA, Sikes M, Bruno-Barcena JM. The intestinal microbiota, gastrointestinal ...
  • Bisgaard H, Li N, Bonnelykke K, Chawes BL, Skov T, ...
  • Gholizadeh P, Mahallei M, Pormohammad A, Varshochi M, Ganbarov K, ...
  • Mouzaki M, Comelli EM, Arendt BM, Bonengel J, Fung SK, ...
  • Ventura M, Canchaya C, Tauch A, Chandra G, Fitzgerald GF, ...
  • Parte A, Whitman W, Goodfellow M, Kämpfer P, Busse H, ...
  • Zhang G, Gao B, Adeolu M, Khadka B, Gupta RS. ...
  • Laureys D, Cnockaert M, De Vuyst L, Vandamme P. Bifidobacterium ...
  • Ventura M, van Sinderen D, Fitzgerald GF, Zink R. Insights ...
  • Hida M, Aiba Y, Sawamura S, Suzuki N, Satoh T, ...
  • Vaziri ND, Yuan J, Rahimi A, Ni Z, Said H, ...
  • Vaziri ND, Wong J, Pahl M, Piceno YM, Yuan J, ...
  • Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD. ...
  • Lau WL, Ix JH. Clinical detection, risk factors, and cardiovascular ...
  • Konstantinov SR, Smidt H, de Vos WM, Bruijns SC, Singh ...
  • van Baarlen P, Troost FJ, van Hemert S, van der ...
  • Simenhoff M, Dunn S, Zollner G, Fitzpatrick M, Emery S, ...
  • Vrieze A, Holleman F, Zoetendal EG, de Vos WM, Hoekstra ...
  • Klindworth A, Pruesse E, Schweer T, Peplies J, Quast C, ...
  • Cruz-Mora J, Martinez-Hernandez NE, Martin del Campo-Lopez F, Viramontes-Horner D, ...
  • Kotanko P, Carter M, Levin NW. Intestinal bacterial microfloraa potential ...
  • Chapkin RS, Seo J, McMurray DN, Lupton JR. Mechanisms by ...
  • Simopoulos AP. Omega-۳ fatty acids in inflammation and autoimmune diseases. ...
  • Brun P, Castagliuolo I, Di Leo V, Buda A, Pinzani ...
  • Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, ...
  • Cani PD, Neyrinck AM, Fava F, Knauf C, Burcelin RG, ...
  • de Goffau MC, Luopajarvi K, Knip M, Ilonen J, Ruohtula ...
  • Evenepoel P, Meijers BK, Bammens BR, Verbeke K. Uremic toxins ...
  • Goetze O, Fruehauf H, Pohl D, Giarre M, Rochat F, ...
  • Taki K, Takayama F, Niwa T. Beneficial effects of Bifidobacteria ...
  • Koppe L, Mafra D, Fouque D. Probiotics and chronic kidney ...
  • نمایش کامل مراجع